tiprankstipranks
Advertisement

MOTG - ETF AI Analysis

Compare

Top Page

MOTG

VanEck Morningstar Global Wide Moat ETF (MOTG)

Rating:57Neutral
Price Target:
MOTG, the VanEck Morningstar Global Wide Moat ETF, has a solid but not top-tier rating, reflecting a mix of strong high-quality companies and a few weaker names. Positive contributors include Bristol-Myers Squibb, Yum China, GlaxoSmithKline, Roche, and Bureau Veritas, which show robust financial performance, healthy growth prospects, and generally supportive technical and valuation signals. However, holdings like Philips, which faces net losses and declining revenues, and some stocks with valuation or technical caution, slightly weigh on the fund’s overall quality, while its broad mix across industries helps limit concentration risk.
Positive Factors
Strong Defense and Industrial Holdings
Several top positions in defense and industrial companies have shown strong recent performance, helping support the ETF’s returns.
Global Diversification
Holdings spread across the U.S., Europe, and Asia reduce reliance on any single country’s economy or market.
Balanced Sector Mix
Exposure to industrials, health care, technology, and consumer sectors provides a mix of growth and stability drivers.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially low, which can slightly reduce long-term returns compared with cheaper ETFs.
Recent Short-Term Weakness
The ETF has experienced weak performance over the last few months, which may signal near-term volatility or pressure.
Stock-Specific Risks in Top Holdings
A few individual holdings, including at least one health care name with weaker recent performance, can weigh on overall results if they continue to lag.

MOTG vs. SPDR S&P 500 ETF (SPY)

MOTG Summary

The VanEck Morningstar Global Wide Moat ETF (MOTG) follows the Morningstar Global Wide Moat Focus Index, which picks companies around the world that have strong, lasting competitive advantages, or “wide moats.” It holds businesses from many countries and sectors, including well-known names like Baidu and Bristol-Myers Squibb, aiming to blend growth potential with quality and stability. An investor might consider MOTG for global diversification and exposure to companies that Morningstar believes can stay profitable over the long term. A key risk is that the ETF’s stock prices can go up or down with global markets, and its focus on select “moat” companies may underperform broader indexes at times.
How much will it cost me?The VanEck Morningstar Global Wide Moat ETF (MOTG) has an expense ratio of 0.52%, which means you’ll pay $5.20 per year for every $1,000 invested. This is slightly higher than average because the fund is actively managed, focusing on selecting companies with strong competitive advantages globally.
What would affect this ETF?The VanEck Morningstar Global Wide Moat ETF (MOTG) could benefit from global economic growth and increased demand for high-quality companies with strong competitive advantages, particularly in sectors like technology, healthcare, and industrials. However, it may face challenges from rising interest rates, which could pressure growth-oriented stocks, and geopolitical tensions affecting key holdings in regions like China and Europe. Regulatory changes in healthcare or technology sectors could also impact the ETF's performance.

MOTG Top 10 Holdings

MOTG’s story right now is written largely by defense and health care. BAE Systems has been a quiet engine for the fund, rising steadily over the past few months, while Thales adds more lift from the global aerospace and defense theme. On the health side, GlaxoSmithKline and Bristol-Myers Squibb have been generally supportive, though their recent trading has been a bit choppy. Offsetting that strength, Baidu has been dragging the fund, and US Bancorp’s weaker trend shows that financials are more of a headwind than a help. The mix is truly global, with meaningful exposure to Europe, the U.S., and China.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
BAE Systems2.69%$452.16K£65.59B43.52%
61
Neutral
2.45%$411.67K
GlaxoSmithKline2.44%$410.45K£78.03B29.26%
77
Outperform
Yum China Holdings2.43%$409.25K$18.27B-1.00%
78
Outperform
Bristol-Myers Squibb2.43%$408.80K$117.06B-5.88%
78
Outperform
Thales2.21%$371.56K€49.80B3.13%
73
Outperform
Roche Holding AG2.14%$359.97K$304.82B12.65%
73
Outperform
US Bancorp2.09%$352.02K$79.63B19.63%
76
Outperform
Bureau Veritas2.05%$345.40K€11.74B-7.03%
76
Outperform
Baidu, Inc. Class A2.02%$339.41KHK$317.88B26.41%
63
Neutral

MOTG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price
Price Trends
50DMA
39.90
Negative
100DMA
39.12
Negative
200DMA
38.08
Negative
Market Momentum
MACD
-0.74
Positive
RSI
26.71
Positive
STOCH
4.20
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MOTG, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 39.04, equal to the 50-day MA of 39.90, and equal to the 200-day MA of 38.08, indicating a bearish trend. The MACD of -0.74 indicates Positive momentum. The RSI at 26.71 is Positive, neither overbought nor oversold. The STOCH value of 4.20 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MOTG.

MOTG Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$16.82M0.52%
57
Neutral
$95.52M1.02%
62
Neutral
$90.76M3.19%
72
Outperform
$77.45M0.69%
68
Neutral
$72.25M0.65%
68
Neutral
$69.02M0.73%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MOTG
VanEck Morningstar Global Wide Moat ETF
36.64
2.94
8.72%
GINX
SGI Enhanced Global Income ETF
ICAP
InfraCap Equity Income Fund ETF
PRAY
FIS Biblically Responsible Risk Managed ETF
SAGP
Strategas Global Policy Opportunities ETF
GOP
Unusual Whales Subversive Republican Trading ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement